These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 16931568)
1. Quantification by liquid chromatography tandem mass spectrometry of mycophenolic acid and its phenol and acyl glucuronide metabolites. Brandhorst G; Streit F; Goetze S; Oellerich M; Armstrong VW Clin Chem; 2006 Oct; 52(10):1962-4. PubMed ID: 16931568 [TBL] [Abstract][Full Text] [Related]
2. High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites. Figurski MJ; Korecka M; Fields L; Waligórska T; Shaw LM Ther Drug Monit; 2009 Dec; 31(6):717-26. PubMed ID: 19809389 [TBL] [Abstract][Full Text] [Related]
3. Quantification of mycophenolic acid and glucuronide metabolite in human serum by HPLC-tandem mass spectrometry. Annesley TM; Clayton LT Clin Chem; 2005 May; 51(5):872-7. PubMed ID: 15746301 [TBL] [Abstract][Full Text] [Related]
4. A high-throughput U-HPLC-MS/MS assay for the quantification of mycophenolic acid and its major metabolites mycophenolic acid glucuronide and mycophenolic acid acyl-glucuronide in human plasma and urine. Klepacki J; Klawitter J; Bendrick-Peart J; Schniedewind B; Heischmann S; Shokati T; Christians U; Klawitter J J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():113-9. PubMed ID: 21839692 [TBL] [Abstract][Full Text] [Related]
5. Sample cleanup-free determination of mycophenolic acid and its glucuronide in serum and plasma using the novel technology of ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry. Kuhn J; Götting C; Kleesiek K Talanta; 2010 Mar; 80(5):1894-8. PubMed ID: 20152429 [TBL] [Abstract][Full Text] [Related]
6. Measurement of mycophenolic acid and its glucuronide using a novel rapid liquid chromatography-electrospray ionization tandem mass spectrometry assay. Kuhn J; Prante C; Kleesiek K; Götting C Clin Biochem; 2009 Jan; 42(1-2):83-90. PubMed ID: 18996104 [TBL] [Abstract][Full Text] [Related]
7. Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit. Shipkova M; Schütz E; Armstrong VW; Niedmann PD; Oellerich M; Wieland E Clin Chem; 2000 Mar; 46(3):365-72. PubMed ID: 10702523 [TBL] [Abstract][Full Text] [Related]
8. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay. Shipkova M; Schütz E; Besenthal I; Fraunberger P; Wieland E Ther Drug Monit; 2010 Feb; 32(1):79-85. PubMed ID: 20042920 [TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatography method for the determination of mycophenolic acid and its acyl and phenol glucuronide metabolites in human plasma. Patel CG; Akhlaghi F Ther Drug Monit; 2006 Feb; 28(1):116-22. PubMed ID: 16418705 [TBL] [Abstract][Full Text] [Related]
10. Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry. Patel CG; Mendonza AE; Akhlaghi F; Majid O; Trull AK; Lee T; Holt DW J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):287-94. PubMed ID: 15556544 [TBL] [Abstract][Full Text] [Related]
11. Sensitive high-performance liquid chromatography-tandem mass spectrometry method for quantitative analysis of mycophenolic acid and its glucuronide metabolites in human plasma and urine. Benoit-Biancamano MO; Caron P; Lévesque E; Delage R; Couture F; Guillemette C J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):159-67. PubMed ID: 17827076 [TBL] [Abstract][Full Text] [Related]
12. Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients. Mino Y; Naito T; Otsuka A; Ushiyama T; Ozono S; Kagawa Y; Kawakami J Clin Biochem; 2009 May; 42(7-8):595-601. PubMed ID: 19100248 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients. Shipkova M; Armstrong VW; Weber L; Niedmann PD; Wieland E; Haley J; Tönshoff B; Oellerich M; Ther Drug Monit; 2002 Jun; 24(3):390-9. PubMed ID: 12021631 [TBL] [Abstract][Full Text] [Related]
14. Determination of Mycophenolic Acid and Mycophenolic Acid Glucuronide Using Liquid Chromatography Tandem Mass Spectrometry (LC/MS/MS). Garg U; Munar A; Frazee C Curr Protoc Toxicol; 2018 Feb; 75():18.21.1-18.21.8. PubMed ID: 29512127 [TBL] [Abstract][Full Text] [Related]
15. Liquid chromatography-tandem mass spectrometry method for the quantification of mycophenolic acid and its phenolic glucuronide in saliva and plasma using a standardized saliva collection device. Wiesen MH; Farowski F; Feldkötter M; Hoppe B; Müller C J Chromatogr A; 2012 Jun; 1241():52-9. PubMed ID: 22552204 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of mycophenolic acid and its glucuronides in human plasma using isocratic ion pair high-performance liquid chromatography. Mino Y; Naito T; Matsushita T; Kagawa Y; Kawakami J J Pharm Biomed Anal; 2008 Feb; 46(3):603-8. PubMed ID: 18164890 [TBL] [Abstract][Full Text] [Related]
17. Mycophenolic Acid Metabolites Acyl-Glucuronide and Glucoside Affect the Occurrence of Infectious Complications and Bone Marrow Dysfunction in Liver Transplant Recipients. Zegarska J; Hryniewiecka E; Żochowska D; Tszyrsznic W; Jaźwiec R; Borowiec A; Pawłowska E; Dadlez M; Pączek L Ann Transplant; 2015 Aug; 20():483-92. PubMed ID: 26313036 [TBL] [Abstract][Full Text] [Related]
18. Development of a Liquid Chromatography-Tandem Mass Spectrometric Method for Quantification of Mycophenolic Acid and Its Glucuronides in Dried Blood Spot Samples. Iboshi H; Yamaguchi H; Suzuki H; Kikuchi M; Tanaka M; Takasaki S; Takahashi A; Maekawa M; Shimada M; Matsuda Y; Okada Y; Mano N Ther Drug Monit; 2017 Dec; 39(6):648-653. PubMed ID: 29040229 [TBL] [Abstract][Full Text] [Related]
19. Stability of mycophenolic acid and glucuronide metabolites in human plasma and the impact of deproteinization methodology. de Loor H; Naesens M; Verbeke K; Vanrenterghem Y; Kuypers DR Clin Chim Acta; 2008 Mar; 389(1-2):87-92. PubMed ID: 18157945 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients. Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]